Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Nature Biotechnology (2022 )Cite this article
To the Editor — The open sharing of clinical data for research poses challenges not only in resolving consent, privacy and intellectual property issues associated with trial results1,2, but also in subsequently facilitating access to and utilization of the data. Controlled-access systems can place onerous restrictions on industry-based researchers, require arduous application processes and involve long review or authorization times for users. Indeed, analyses of major efforts, such as ClinicalStudyDataRequest.com (CSDR)3,4 and the UK Health Research Authority’s (HRA) Assessment Review Portal (HARP) database5, suggest that fewer than 50% of the available trial datasets in these resources have been accessed and analyzed by researchers after launch. Here, we outline several strategies that ensured that researcher-engagement with an open-access ALS clinical trial data resource reached its full potential. We hope that our insights will be instructive for others seeking to galvanize open clinical data sharing efforts within the broader research community.
This is a preview of subscription content
Get full journal access for 1 year
All prices are NET prices. VAT will be added later in the checkout. Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Longo, D. L. & Drazen, J. M. N. Engl. J. Med. 374, 276–277 (2016).
Ohmann, C. et al. BMJ Open 7, e018647 (2017).
Kochhar, S. et al. BMJ Open 9, e032334 (2019).
Vaduganathan, M. et al. Circulation 137, 938–947 (2018).
Trace, S., Bracher, M. & Kolstoe, S. E. BMJ Open 10, e039756 (2020).
Atassi, N. et al. Neurology 83, 1719–1725 (2014).
Kueffner, R. et al. Sci. Rep. 9, 690 (2019).
Meyer, P. & Saez-Rodriguez, J. Cell Syst. 12, 636–653 (2021).
Küffner, R. et al. Nat. Biotechnol. 33, 51–57 (2015).
Taylor, A. A. et al. Ann. Clin. Transl. Neurol. 3, 866–875 (2016).
Berry, J. D. et al. Ann. Clin. Transl. Neurol. 5, 474–485 (2018).
Jahandideh, S. et al. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 294–302 (2018).
Conrado, D. J. et al. J. Pharmacokinet. Pharmacodyn. 46, 441–455 (2019).
Takeda Pharmaceuticals, Cambridge, MA, USA
Accelerating NeuroVentures, LLC, Needham, MA, USA
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
N.Z. is an employee of Takeda Pharmaceuticals.
Zach, N., Leitner, M.L. PRO-ACTive sharing of clinical data. Nat Biotechnol (2022). https://doi.org/10.1038/s41587-022-01395-y
DOI: https://doi.org/10.1038/s41587-022-01395-y
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Nature Biotechnology (Nat Biotechnol) ISSN 1546-1696 (online) ISSN 1087-0156 (print)
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.